Orchard Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-191,933
Closed -$3.1M 45
2020
Q4
$3.1M Buy
+191,933
New +$2.38M 1.32% 31

Orchard Capital Management's UROV Position: Q1 2021 in Review

Orchard Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 191,933 shares — an estimated $3.1M sold.

Orchard Capital Management first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $3.1M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Orchard Capital Management reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Orchard Capital Management sold 191,933 Urovant Sciences Ltd. shares in Q1 2021, an estimated $3.1M.
  • Orchard Capital Management first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Orchard Capital Management's Urovant Sciences Ltd. position peaked at $3.1M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Orchard Capital Management's 13F filing for Q1 2021, filed 13 May 2021.